MENU
Showcases Stock ranks Forex

Pfizer Inc (PFE)
49.86  0.11 (0.22%) 08-16 16:04
Open: 49.38 Pre. Close: 49.75
High: 50.18 Low: 49.36
Volume: 12,519,784 Market Cap: 279,832M
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Prices Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 50.227 - 50.47 50.47 - 50.68
Low: 48.774 - 49.057 49.057 - 49.301
Close: 49.438 - 49.875 49.875 - 50.252
Stock Technical Analysis
Overall:     
Target: Six months: 59.48
One year: 61.73
Support: Support1: 47.81
Support2: 39.78
Resistance: Resistance1: 50.92
Resistance2: 52.85
Pivot: 49.98
Moving Averages: MA(5): 49.59
MA(20): 50.35
MA(100): 51.02
MA(250): 50.24
MACD: MACD(12,26): -0.47
Signal(12,26,9): -0.43
%K %D: %K(14,3): 43.16
%D(3): 33.79
RSI: RSI(14): 46.48
52-Week: High: 61.71
Low: 40.94
Change(%): 3.1
Average Vol(K): 3-Month: 20385
10-Days: 18343
Price, MAs and Bollinger Bands
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.

[ PFE ] has closed above bottom band by 46.0%. Bollinger Bands are 43.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.
Stock chart
Stock News
Tue, 16 Aug 2022
Where Will Pfizer Inc. (PFE) Stock Go Next After It Has Fallen 0.32% in a Week? - InvestorsObserver

Tue, 16 Aug 2022
Pacific Center for Financial Services Lowers Stake in Pfizer Inc. (NYSE:PFE) - Defense World

Mon, 15 Aug 2022
Statement from Pfizer Chairman and CEO Albert Bourla on Testing Positive for COVID-19 - Pfizer

Tue, 09 Aug 2022
ClearBridge All Cap Value Strategy Added Pfizer Inc. (PFE) in its Portfolio - Yahoo Sports

Mon, 08 Aug 2022
Pfizer to Buy Global Blood Therapeutics in $5.4 Billion Deal - Bloomberg

Fri, 05 Aug 2022
Is Pfizer Inc. (PFE) Stock a Smart Value? - InvestorsObserver

Financial Analysis
Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Outperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Outperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Exchange:  New York Stock Exchange
Sector:  Healthcare
Industry:  Drug Manufacturers—General
Shares Out. (M) 5610.00
Shares Float (M) 5610.00
% Held by Insiders 0.04
% Held by Institutions 69.13
Shares Short (K) 67350
Shares Short Prior Month (K) 76980
Stock Financials
EPS 5.180
Book Value (p.s.) 14.740
Profit Margin 28.94
Operating Margin 37.61
Return on Assets (ttm)
Return on Equity (ttm)
Qtrly Rev. Growth 46.2
Gross Profit (p.s.) 9.025
Sales Per Share 18.053
EBITDA (p.s.) 7.676
Qtrly Earnings Growth 76.40
Operating Cash Flow (M)
Levered Free Cash Flow (M)
Stock Valuation
PE Ratio 9.63
PEG Ratio
Price to Book value 3.38
Price to Sales 2.76
Price to Cash Flow
Stock Dividends
Dividend 0.400
Dividend Yield 0.01
Dividend Growth

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android